White label – Pompe disease - ClinicalTrials.eu

Study for Myelofibrosis Patients Using Ruxolitinib or Ruxolitinib with Other Cancer Treatments

Recruiting

2 1 1 1
Investigated Drugs:
- Ruxolitinib
Long-term Safety Study of CRISPR CAR T Cell Therapy for Patients with Blood and Solid Cancers

Recruiting

1 1 1
Investigated Diseases:
- Haematological malignancy
Investigated Drugs:
- Allogeneic Crispr/Cas9-Mediated Genetically Modified Car T Cells Targeting Cd19 Antigen
Study on the Safety of Lanreotide and Metformin for Patients with Advanced Gastrointestinal or Lung Carcinoids

Recruiting

2 1 1 1
Investigated Diseases:
- Gastrointestinal carcinoma
- Lung neoplasm malignant
Investigated Drugs:
- Lanreotide
- Metformin Hydrochloride
Study on Retinoblastoma Treatment: Evaluating the Effectiveness of Topotecan, Vincristine Sulfate, and Etoposide in Patients Eligible for Conservative Therapy

Recruiting

2 1 1 1
Investigated Diseases:
- Retinoblastoma
Investigated Drugs:
Long-Term Safety Study of ACP-204 for Adults with Alzheimer’s Disease Psychosis

Recruiting

3 1 1
Investigated Diseases:
- Dementia Alzheimer’s type
Investigated Drugs:
- Acp-204 Tartrate
Study on the Safety and Effectiveness of Linvoseltamab, Sarilumab, and Dexamethasone in Adults with Relapsed or Refractory AL Amyloidosis

Recruiting

1 1 1 1
Investigated Diseases:
- Primary amyloidosis
Investigated Drugs:
Study on the Safety and Effectiveness of TZ-161 for Adults with Early Acute Spinal Cord Injury

Recruiting

1 1 1 1
Investigated Drugs:
- Eletriptan
Evaluation of Bevacizumab in Patients with Brain Radionecrosis After Radiation Treatment for Brain Metastases

Recruiting

3 1 1
Investigated Diseases:
- Metastases to central nervous system
Investigated Drugs:
Study on the Effectiveness of 2LEBV and 2LXFS for Reducing Fatigue in Patients with Epstein-Barr Virus Infection

Recruiting

3 1 1
Investigated Diseases:
- Epstein-Barr virus infection
- Epstein-Barr virus infection reactivation
Investigated Drugs:
Study on Darolutamide and Radiation Therapy for Patients with Castration-Resistant Prostate Cancer and Oligometastases

Recruiting

3 1 1 1
Investigated Diseases:
- Hormone-refractory prostate cancer
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies